Results for leflunomiid translation from Estonian to English

leflunomiid
leflunomide

arava leflunomiid
arava leflunomide

leflunomide teva leflunomiid
leflunomide teva leflunomide

toimeaine on leflunomiid.
the active substance is leflunomide.

leflunomide medac leflunomiid
leflunomide medac leflunomide

leflunomiid ei olnud mutageenne.
leflunomide was not mutagenic.

leflunomiid on näidustatud täiskasvanud patsientidel:
leflunomide is indicated for the treatment of adult patients with:

leflunomide ratiopharm 10 mg tabletid leflunomiid
leflunomide ratiopharm 10 mg tablets leflunomide

need ravivõimalused on metotreksaat, leflunomiid, hüdroksüklorokiin,
these therapies include methotrexate, leflunomide, hydroxychloroquine, sulfasalazine and/ or gold salts.

arava 100 mg õhukese polümeerikattega tabletid leflunomiid
arava 100 mg film-coated tablets leflunomide

repso, 10 mg õhukese polümeerikattega tabletid leflunomiid
repso 10 mg film-coated tablets leflunomide

leflunomide teva, 10 mg õhukese polümeerikattega tabletid leflunomiid
leflunomide teva 10 mg film-coated tablets leflunomide

leflunomiid on antiproliferatiivsete omadustega haigust moduleeriv antireumaatiline aine.
leflunomide is a disease-modifying anti-rheumatic agent with antiproliferative properties.

kartsinogeensuse uuringutes rottidel ei omanud leflunomiid kartsinogeenset toimet.
in a carcinogenicity study in rats, leflunomide did not show carcinogenic potential.

uuringus mn302 osutus leflunomiid oluliselt vähem efektiivseks kui metotreksaat.
in study mn302 leflunomide was significantly less effective than methotrexate.

loomkatsed on näidanud, et leflunomiid ja selle metaboliidid erituvad rinnapiima.
animal studies indicate that leflunomide or its metabolites pass into breast milk.

aravas toimeainena sisalduv leflunomiid on immunosupressant (immuunvastust vähendav aine).
the active substance in arava, leflunomide, is an immunosuppressant.

need ravivõimalused on metotreksaat, leflunomiid, hüdroksüklorokiin, sulfasalasiin ja/või kullasoolad.
these therapies include methotrexate, leflunomide, hydroxychloroquine, sulfasalazine and/or gold salts.

leflunomide medacis toimeainena sisalduv leflunomiid on immunosupressant (immuunvastust vähendav aine).
the active substance in leflunomide medac, leflunomide, is an immunosuppressant.

ohutuse osas olid kõrvalnähud sarnased immunosupressant leflunomiidi kõrvalnähtudega, sest leflunomiid muutub organismis teriflunomiidiks.
regarding its safety, side effects were similar to the immunosuppressant leflunomide, as leflunomide is converted into teriflunomide in the body.